Combining chemotherapy and targeted therapies in metastatic colorectal cancer

Por Rodriguez, J, Zarate, R, Bandres, E, Viudez, A, Chopitea, A, García-Foncillas, J, Gil-Bazo, I
Publicado em 2007

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What’s new?

Por Ponz-Sarvisé, M, Rodríguez, J, Viudez, A, Chopitea, A, Calvo, A, García-Foncillas, J, Gil-Bazo, I
Publicado em 2007

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

Por Zarate, R, Rodríguez, J, Bandres, E, Patiño-Garcia, A, Ponz-Sarvise, M, Viudez, A, Ramirez, N, Bitarte, N, Chopitea, A, Gacía-Foncillas, J
Publicado em 2010

Stellate cells, a point of light in the dark night of pancreatic cancer

Por Ramírez, N, Viúdez, A, Hernández-García, I, Guerrero, D, Gómez-Dorronsoro, M, Herrera, F J, Vila, J, Beloki, L, Ciaúrriz, M, Mansilla, C, Vera, R
Publicado em 2014

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of tra...

Por Custodio, A, Carmona-Bayonas, A, Jiménez-Fonseca, P, Sánchez, M L, Viudez, A, Hernández, R, Cano, J M, Echavarria, I, Pericay, C, Mangas, M, Visa, L, Buxo, E, García, T, Rodríguez Palomo, A, Álvarez Manceñido, F, Lacalle, A, Macias, I, Azkarate, A, Ramchandani, A, Fernández Montes, A, López, C, Longo, F, Sánchez Bayona, R, Limón, M L, Díaz-Serrano, A, Hurtado, A, Madero, R, Gómez, C, Gallego, J
Publicado no Br J Cancer (2017)